Physical health and incident late-life depression: Modification by cytokine genes

Neurobiology of Aging

Volumn 34, Issue 1, 2013, Pages 356.e1-356.e9

  Kim, Jae Min ^a   Stewart, Robert ^b   Kim, Sung Wan ^a   Kim, Seon Young ^a   Bae, Kyung Yeol ^a   Kang, Hee Ju ^a   Jang, Ji Eun ^a   Shin, Il Seon ^a   Yoon, Jin Sang ^a  

^a Chonnam National University Medical School   (South Korea)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cytokines; Depression; Genetics; Interleukins; Physical disorder

Indexed keywords

EID: 84868096010     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.01.111     Document Type: Article

References (51)

1. Anovazzi G., Kim Y.J., Viana A.C., Curtis K.M., Orrico S.R., Cirelli J.A., Scarel-Caminaga R.M. Polymorphisms and haplotypes in the interleukin-4 gene are associated with chronic periodontitis in a Brazilian population. J. Periodontol 2010, 81:392-402.
2. Beamer N.B., Coull B.M., Clark W.M., Hazel J.S., Silberger J.R. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann. Neurol 1995, 37:800-805.
3. Bull S.J., Huezo-Diaz P., Binder E.B., Cubells J.F., Ranjith G., Maddock C., Miyazaki C., Alexander N., Hotopf M., Cleare A.J., Norris S., Cassidy E., Aitchison K.J., Miller A.H., Pariante C.M. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol. Psychiatry 2009, 14:1095-1104.
4. Caspi A., Hariri A.R., Holmes A., Uher R., Moffitt T.E. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am. J. Psychiatry 2010, 167:509-527.
5. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., Poulton R. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
6. Cerri A.P., Arosio B., Viazzoli C., Confalonieri R., Vergani C., Annoni G. The -308 (G/A) single nucleotide polymorphism in the TNF-α gene and the risk of major depression in the elderly. Int. J. Geriatr. Psychiatry 2010, 25:219-223.
7. Copeland J.R., Dewey M.E., Griffiths-Jones H.M. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol. Med 1986, 16:89-99.
8. Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Ann. N. Y. Acad. Sci 2001, 933:222-234.
9. de Craen A.J., Posthuma D., Remarque E.J., van den Biggelaar A.H., Westendorp R.G., Boomsma D.I. Heritability estimates of innate immunity: an extended twin study. Genes Immun 2005, 6:167-170.
10. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., LanctÔt K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
11. Hoffman C., Rice D., Sung H.Y. Persons with chronic conditions. Their prevalence and costs. JAMA 1996, 276:1473-1479.
12. Hull J., Thomson A., Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 2000, 55:1023-1027.
13. Hwang J.P., Tsai S.J., Hong C.J., Yang C.H., Hsu C.D., Liou Y.J. Interleukin-1 beta -511C/T genetic polymorphism is associated with age of onset of geriatric depression. Neuromolecular Med 2009, 11:322-327.
14. Janeway C.A., Travers P. Immunobiology. The Immune System in Health and Disease 1997, Current Biology/Garland Publishing, New York. third ed.
15. Jun T.Y., Pae C.U., Hoon-Han H., Chae J.H., Bahk W.M., Kim K.S., Serretti A. Possible association between -G308A tumour necrosis factor-α gene polymorphism and major depressive disorder in the Korean population. Psychiatr. Genet 2003, 13:179-181.
16. Katon W.J. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol. Psychiatry 2003, 54:216-226.
17. Kim J.M., Stewart R., Glozier N., Prince M., Kim S.W., Yang S.J., Shin I.S., Yoon J.S. Physical health, depression and cognitive function as correlates of disability in an older Korean population. Int. J. Geriatr. Psychiatry 2005, 20:160-167.
18. Kim J.M., Stewart R., Kim S.W., Yang S.J., Shin I.S., Kim Y.H., Yoon J.S. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol. Psychiatry 2007, 62:423-428.
19. Kim J.M., Stewart R., Kim S.W., Yang S.J., Shin I.S., Yoon J.S. Predictive value of folate, vitamin B12 and homocysteine levels in late-life depression. Br. J. Psychiatry 2008, 192:268-274.
20. Kim J.M., Stewart R., Kim S.W., Yang S.J., Shin I.S., Yoon J.S. Modification by two genes of associations between general somatic health and incident depressive syndrome in older people. Psychosom. Med 2009, 71:286-291.
21. Kim J.M., Stewart R., Prince M., Shin I.S., Yoon J.S. Diagnosing dementia in a developing nation: an evaluation of the GMS-AGECAT algorithm in an older Korean population. Int. J. Geriatr. Psychiatry 2003, 18:331-336.
22. Lindesay J. The Guy's/Age Concern Survey: physical health and psychiatric disorder in an urban elderly community. Int. J. Geriatr. Psychiatry 1990, 5:171-178.
23. Maes M., Bosmans E., Meltzer H.Y., Scharpé S., Suy E. Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?. Am. J. Psychiatry 1993, 150:1189-1193.
24. Mattila K.M., Rinne J.O., Lehtimäki T., Röyttä M., Ahonen J.P., Hurme M. Association of an interleukin 1B gene polymorphism (-511) with Parkinson's disease in Finnish patients. J. Med. Genet 2002, 39:400-402.
25. McCulley M.C., Day I.N., Holmes C. Association between interleukin 1-β promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet 2004, 124B:50-53.
26. McCusker S.M., Curran M.D., Dynan K.B., McCullagh C.D., Urquhart D.D., Middleton D., Patterson C.C., McIlroy S.P., Passmore A.P. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet 2001, 357:436-439.
27. Milaneschi Y., Corsi A.M., Penninx B.W., Bandinelli S., Guralnik J.M., Ferrucci L. Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study. Biol. Psychiatry 2009, 65:973-978.
28. Misener V.L., Gomez L., Wigg K.G., Luca P., King N., Kiss E., Daróczi G., Kapornai K., Tamas Z., Mayer L., Gádoros J., Baji I., Kennedy J.L., Kovacs M., Vetró A., Barr C.L. Cytokine genes TNF, IL1A, IL1β, IL6, IL1RN and IL10, and childhood-onset mood disorders. Neuropsychobiology 2008, 58:71-80. International Consortium for Childhood-Onset Mood Disorders.
29. Moussavi S., Chatterji S., Verdes E., Tandon A., Patel V., Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007, 370:851-858.
30. Musselman D.L., Lawson D.H., Gumnick J.F., Manatunga A.K., Penna S., Goodkin R.S., Greiner K., Nemeroff C.B., Miller A.H. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J. Med 2001, 344:961-966.
31. Otte C., McCaffery J., Ali S., Whooley M.A. Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am. J. Psychiatry 2007, 164:1379-1384.
32. Park J.H., Kwon Y.C. Modification of the mini-mental state examination for use in the elderly in a non-western society: Part I. Development of Korean version of Mini-Mental State Examination. Int. J. Geriatr. Psychiatry 1990, 5:381-387.
33. Patten S.B. Long-term medical conditions and major depression in a Canadian population study at waves 1 and 2. J. Affect. Disord 2001, 63:35-41.
34. Penninx B.W., Kritchevsky S.B., Yaffe K., Newman A.B., Simonsick E.M., Rubin S., Ferrucci L., Harris T., Pahor M. Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol. Psychiatry 2003, 54:566-572.
35. Perini F., Morra M., Alecci M., Galloni E., Marchi M., Toso V. Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurol. Sci 2001, 22:289-296.
36. Prince M., Acosta D., Chiu H., Scazufca M., Varghese M. Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet 2003, 361:909-917. 10/66 Dementia Research Group.
37. Prince M.J., Harwood R.H., Thomas A., Mann A.H. A prospective population-based cohort study of the effects of disablement and social milieu on the onset and maintenance of late-life depression. The Gospel Oak Project VII. Psychol. Med 1998, 28:337-350.
38. Rosa A., Peralta V., Papiol S., Cuesta M.J., Serrano F., Martínez-Larrea A., Fañanás L. Interleukin-1beta (IL-1beta) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet 2004, 124B:10-14.
39. Schiepers O.J., Wichers M.C., Maes M. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:201-217.
40. Stoica A.L., Stoica E., Constantinescu I., Uscatescu V., Ginghina C. Interleukin-6 and interleukin-10 gene polymorphism, endothelial dysfunction, and postoperative prognosis in patients with peripheral arterial disease. J. Vasc. Surg 2010, 52:103-109.
41. Su K.P., Huang S.Y., Peng C.Y., Lai H.C., Huang C.L., Chen Y.C., Aitchison K.J., Pariante C.M. Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biol. Psychiatry 2010, 67:550-557.
42. Sullivan P.F., Neale M.C., Kendler K.S. Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiatry 2000, 157:1552-1562.
43. Thomas A.J., Davis S., Morris C., Jackson E., Harrison R., O'Brien J.T. Increase in interleukin-1β in late-life depression. Am. J. Psychiatry 2005, 162:175-177.
44. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnot P.J., Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet 1997, 24:1-8.
45. Vila N., Castillo J., Dávalos A., Esteve A., Planas A.M., Chamorro A. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke 2003, 34:671-675.
46. Wang C.Y., Shen Y.C., Su C.H., Lo F.Y., Lee S.H., Tsai H.Y., Fan S.S. Investigation of the association between interleukin-1β polymorphism and normal tension glaucoma. Mol. Vis 2007, 14:719-723.
47. Wells K.B., Golding J.M., Burnam M.A. Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am. J. Psychiatry 1988, 145:976-981.
48. Wilson A.G., Symons J.A., McDowell T.L., Mcdevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:3195-3199.
49. Yirmiya R. Behavioral and psychological effects of immune activation: implications for "depression due to a general medical condition.". Curr. Opin. Psychiatry 1997, 10:470-476.
50. Yirmiya R., Pollak Y., Morag M., Reichenberg A., Barak O., Avitsur R., Shavit Y., Ovadia H., Weidenfeld J., Morag A., Newman M.E., Pollmächer T. Illness, cytokines, and depression. Ann. N. Y. Acad. Sci 2000, 917:478-487.
51. Yu Y.W., Chen T.J., Hong C.J., Chen H.M., Tsai S.J. Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology 2003, 28:1182-1185.